Trials / Completed
CompletedNCT06063837
Live Instruction and Fitness Tracking*: A 12-week Combined Aerobic and Resistance Training Intervention
The Implementation of a Community-health Focused Intervention Using Combined Aerobic and Resistance Training Protocols in a Group Setting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Maryland Eastern Shore · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This project was a 12-week aerobic and resistance training intervention that included participants meeting at a pre-determined location from 1-2 times per week for 12 weeks. Aerobic activity was walking. Resistance training included traditional and non-traditional implements.
Detailed description
The 12-week program included a 60-minute session. Participants filled out a Physical Activity Readiness Questionnaire and completed pre-exercise fitness tests. The fitness tests included the curl up, pushup, and a 1.5 mile walk test. The session involved a warmup which included stretching followed by a 5-min walk for a total of 10 minutes. Functional bodyweight and resistance training exercises were implemented and supervised by the principal investigator (PI) who specializes in program design and implementation. The exercises targets major muscle groups such as legs, chest, back, and shoulders. The resistance training portion took 30-35 minutes. Steady-state aerobic activity which included walking took place at the end of the session for 10-15 minutes. The intensity was monitored using self-rated RPE scores which participants would report to the PI following each session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Live Instruction and Fitness Tracking (LIFT-up) | A 12-week combined aerobic and resistance training exercise protocol |
Timeline
- Start date
- 2023-01-24
- Primary completion
- 2023-04-13
- Completion
- 2023-04-28
- First posted
- 2023-10-03
- Last updated
- 2023-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06063837. Inclusion in this directory is not an endorsement.